Melanoma Research

Papers
(The H4-Index of Melanoma Research is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Temozolomide monotherapy versus combination therapies in melanoma: a meta-analysis of efficacy and safety21
A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockade17
Genetic concordance in melanoma: insights from primary tumors and their matched distant metastases17
Eruptive melanocytic nevi in a patient with amelanotic melanoma: a paraneoplastic phenomenon?16
Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors16
Polymorphisms in toll-like receptor 3 and 4 genes as prognostic and outcome biomarkers in melanoma patients12
Treatment reality of patients with BRAF-mutant advanced/metastatic melanoma in Switzerland in the era of choice12
Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma11
Management of metastatic bone disease of melanoma10
Targeting beta-adrenergic receptor pathways in melanoma: how stress modulates oncogenic immunity10
Efficacy of topical diphencyprone for melanoma in-transit metastases: a systematic review and meta-analysis10
Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel10
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma10
Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors10
Genetic causal relationship between gut microbiota and cutaneous melanoma: a two-sample Mendelian randomization study10
Simultaneous melanomas in the setting of multiple primary melanomas10
0.053961038589478